Gut microbiota characteristics and targeted tryptophan metabolomics in premature ejaculation patients with depressive state: a cross-sectional study

Background: The gut microbiota-tryptophan metabolic axis has emerged as a potential modulator of neuropsychiatric disorders, yet its role in premature ejaculation (PE) comorbid with depressive states remains unexplored. Methods: Fifteen eligible PE patients were enrolled. Depressive status was assessed using the Patient Health Questionnaire-9 (PHQ-9), dividing participants into a depressive-state group (n = 9) and a non-depressive group (n = 6). Demographic and clinical data, including age, body mass index (BMI), International Index of Erectile Function-5 (IIEF-5), Premature Ejaculation Diagnostic Tool (PEDT) scores, total testosterone (TT), and free testosterone (FT) levels, were recorded. Fecal samples underwent 16S rRNA sequencing for gut microbiota profiling, while serum samples were subjected to targeted tryptophan metabolomic analysis. Associations between gut microbiota and tryptophan metabolites were evaluated using Spearman’s correlation. Results: The depressive-state group exhibited a significantly higher abundance of Desulfobacterota (phylum level: relative abundance 0.12% vs. 0.08%, p = 0.04; absolute abundance 5.9 × 106 vs. 2.1 × 105 copies/g, p = 0.007) and lower serum kynurenic acid (KYNA) levels (0.005 ± 0.002 vs. 0.009 ± 0.003 µg/mL, p = 0.006) compared to the non-depressive group. A significant negative correlation was observed between Desulfobacterota abundance and KYNA levels (r = −0.66, p = 0.016). Conclusions: PE patients with depressive states demonstrate altered gut microbiota features—characterized by elevated Desulfobacterota abundance at multiple taxonomic levels—and suppressed serum KYNA concentrations, which are inversely correlated. These findings suggest that depressive status may disturb gut microbiota-tryptophan metabolic interactions, highlighting its potential as a therapeutic target for personalized PE management. Clinical Trial Registration: https://trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2400079838, ChiCTR2400079838.

Premature ejaculation; Gut microbiota; Tryptophan metabolism; Depression

[1] Hou G, Gao M, Zhang L, Dun X, Zheng Y, Wang F, et al. An internally validated nomogram for predicting the likelihood of improvement of clinical global impression in patients with lifelong premature ejaculation treated with dapoxetine. The Journal of Sexual Medicine. 2020; 17: 2341–2350.

[2] van Raaij JJ, Serefoglu EC, van Amelsvoort TAMJ, Janssen PKC. Possible pathophysiologic roles of neurotransmitter systems in men with lifelong premature ejaculation: a scoping review. Sexual Medicine Reviews. 2024; 12: 638–651.

[3] Chen X, Wang FX, Hu C, Yang NQ, Dai JC. Penile sensory thresholds in subtypes of premature ejaculation: implications of comorbid erectile dysfunction. Asian Journal of Andrology. 2018; 20: 330–335.

[4] Guo L, Liu Y, Wang X, Yuan M, Yu Y, Zhang X, et al. Significance of penile hypersensitivity in premature ejaculation. Scientific Reports. 2017; 7: 10441.

[5] Lee HY, Pyun JH, Shim SR, Kim JH. Efficacy of various treatment in premature ejaculation: systematic review and network meta-analysis. World Journal of Men’s Health. 2024; 42: 338–346.

[6] Hestad K, Alexander J, Rootwelt H, Aaseth JO. The role of tryptophan dysmetabolism and quinolinic acid in depressive and neurodegenerative diseases. Biomolecules. 2022; 12: 998.

[7] Xue C, Li G, Zheng Q, Gu X, Shi Q, Su Y, et al. Tryptophan metabolism in health and disease. Cell Metabolism. 2023; 35: 1304–1326.

[8] Zhu T, Gao P, Gao J, Liu X, Jiang H, Zhang X. The upregulation of tryptophan hydroxylase-2 expression is important for premature ejaculation treatment with the selective serotonin reuptake inhibitor. Andrology. 2022; 10: 595–603.

[9] Shindel AW, Althof SE, Carrier S, Chou R, McMahon CG, Mulhall JP, et al. Disorders of ejaculation: an AUA/SMSNA guideline. The Journal of Urology. 2022; 207: 504–512.

[10] Raisi F, Soleimani R, Ahmadzadeh A, Sadati SN, Fakhrian A, Jalali MM. Efficacy and safety of pharmacological treatments in patients with premature ejaculation: an umbrella review of meta-analyses of randomized controlled trials. The Journal of Sexual Medicine. 2025; 22: 1014–1023.

[11] Savitz J. The kynurenine pathway: a finger in every pie. Molecular Psychiatry. 2020; 25: 131–147.

[12] Bryleva EY, Brundin L. Kynurenine pathway metabolites and suicidality. Neuropharmacology. 2017; 112: 324–330.

[13] Walker AK, Wing EE, Banks WA, Dantzer R. Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice. Molecular Psychiatry. 2019; 24: 1523–1532.

[14] Pu J, Liu Y, Zhang H, Tian L, Gui S, Yu Y, et al. An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder. Molecular Psychiatry. 2021; 26: 4265–4276.

[15] Zhou M, Fan Y, Xu L, Yu Z, Wang S, Xu H, et al. Microbiome and tryptophan metabolomics analysis in adolescent depression: roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice. Microbiome. 2023; 11: 145.

[16] Mhanna A, Martini N, Hmaydoosh G, Hamwi G, Jarjanazi M, Zaifah G, et al. The correlation between gut microbiota and both neurotransmitters and mental disorders: a narrative review. Medicine. 2024; 103: e37114.

[17] Cryan JF. Microbiome and brain development: a tale of two systems. Annals of Nutrition and Metabolism. 2025; 81: 34–46.

[18] Chen L, Li Z, Fan Y. Neurodevelopmental disorders and gut-brain interactions: exploring the therapeutic potential of pycnogenol through microbial-metabolic-neural networks. Frontiers in Cellular and Infection Microbiology. 2025; 15: 1601888.

[19] Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− mice. Nature. 2012; 487: 104–108.

[20] Maldonado-Arriaga B, Sandoval-Jiménez S, Rodríguez-Silverio J, Lizeth Alcaráz-Estrada S, Cortés-Espinosa T, Pérez-Cabeza de Vaca R, et al. Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis. Microbiologyopen. 2021; 10: e1181.

[21] Aho VTE, Houser MC, Pereira PAB, Chang J, Rudi K, Paulin L, et al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease. Molecular Neurodegeneration. 2021; 16: 6.

[22] Mohammadi K, Zhang D, Erik Joakim Saris P. Strain-specific effects of desulfovibrio on neurodegeneration and oxidative stress in a caenorhabditis elegans PD model. NPJ Parkinson’s Disease. 2025; 11: 236.

[23] Plitman E, Iwata Y, Caravaggio F, Nakajima S, Chung JK, Gerretsen P, et al. Kynurenic acid in schizophrenia: a systematic review and meta-analysis. Schizophrenia Bulletin. 2017; 43: 764–777.

[24] Ostapiuk A, Urbanska EM. Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword? CNS Neuroscience & Therapeutics. 2022; 28: 19–35.

[25] Hansen KB, Yi F, Perszyk RE, Furukawa H, Wollmuth LP, Gibb AJ, et al. Structure, function, and allosteric modulation of NMDA receptors. Journal of General Physiology. 2018; 150: 1081–1105.

[26] Lukács M, Warfvinge K, Tajti J, Fülöp F, Toldi J, Vécsei L, et al. Topical dura mater application of CFA induces enhanced expression of c-fos and glutamate in rat trigeminal nucleus caudalis: attenuated by KYNA derivate (SZR72). The Journal of Headache and Pain. 2017; 18: 39.

[27] Xia JD, Chen F, Zhang QJ, Wang YM, Dai YT, Song NH, et al. Abnormal thalamic metabolism in patients with lifelong premature ejaculation. The Journal of Sexual Medicine. 2021; 18: 275–283.

[28] Wu C, Huang S, Liu Z, Wang Y, Zhu Y, Zang ZJ. Correlation between serum tryptophan metabolism and treatment efficacy of dapoxetine in patients with premature ejaculation: a pilot study. Andrology. 2024; 12: 1830–1840.

[29] Yang J, Luan JC, Chen JH, Zhang QJ, Xue JX, Wang YM, et al. Prostate-derived IL-1β upregulates expression of NMDA receptor in the paraventricular nucleus and shortens ejaculation latency in rats with experimental autoimmune prostatitis. Asian Journal of Andrology. 2022; 24: 213–218.

[30] Wagan AA, Chandio SA, Surahyo P. Premature ejaculatory dysfunction in rheumatoid arthritis (PED-RA Study). Pakistan Journal of Medical Sciences. 2022; 38: 2131–2136.